| 1 |
neutralizing antibodies
(892 times)
|
Virology
(157 times)
|
SARS-CoV-2 (78 times)
RBD (75 times)
COVID-19 (67 times)
|
1988 Rapid (24h) neutralization assay for the detection of antibodies to human cytomegalovirus using a monoclonal antibody to an HCMV early nuclear protein.
|
| 2 |
Neutralizing antibodies
(97 times)
|
Neurology
(15 times)
|
SARS-CoV-2 (14 times)
MS (12 times)
IFNbeta (10 times)
|
2004 Neutralizing antibodies to multiple sclerosis treatments.
|
| 3 |
neutralising antibodies
(66 times)
|
Neurology
(15 times)
|
MS (12 times)
IFNbeta (7 times)
IFN (4 times)
|
2000 [Neutralizing antibodies in patients with multiple sclerosis treated with interferon beta-1b].
|
| 4 |
natural antibodies
(42 times)
|
Allergy and Immunology
(9 times)
|
mAbs (3 times)
WT (3 times)
ELISA (2 times)
|
1997 Pig to monkey bone marrow and kidney xenotransplantation.
|
| 5 |
naturally occurring autoantibodies
(35 times)
|
Medicine
(14 times)
|
PD (7 times)
Ig (5 times)
RBC (5 times)
|
2001 The structure of anti-Gal immunoglobulin genes in naive and stimulated Gal knockout mice.
|
| 6 |
Natural antibodies
(24 times)
|
Allergy and Immunology
(9 times)
|
oxLDL (2 times)
PC (2 times)
AD (1 time)
|
1998 Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column.
|
| 7 |
SARS-CoV-2-neutralizing antibodies
(4 times)
|
Cell Biology
(1 time)
|
COVID-19 (2 times)
RBD (2 times)
SARS-CoV-2 (2 times)
|
2020 Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
|
A Search Service for Abbreviation / Long Form